SCHEMBL19880512

SCHEMBL19880512

CCC(C)c1nccc(/C=N/S)c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20621302 0.83 ADRA2A (0.33) —
SCHEMBL24574394 0.81 USP2 (0.30) —
SCHEMBL20621309 0.80 — —
SCHEMBL18978721 0.74 USP2 (0.37) —
SCHEMBL18978703 0.74 USP2 (0.37) —
SCHEMBL20621321 0.73 NOS2 (0.48) —
SCHEMBL23046372 0.71 TSHR (0.32) —
SCHEMBL20621434 0.69 L3MBTL1 (0.38) —
SCHEMBL21173560 0.69 ALDH1A1 (0.33) —
SCHEMBL19780270 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 — — US disclosed
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 — — US disclosed
Send feedback